Akonni Biosystems Inc, Product Pipeline Analysis - 2019 Update - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Akonni Biosystems Inc - Product Pipeline Analysis, 2019 Update" company profile has been added to ResearchAndMarkets.com's offering.

Summary

Akonni Biosystems Inc (Akonni Biosystems) is a molecular diagnostics company that develops, manufactures, and distributes integrated molecular diagnostic systems. The company provides product such as nucleic acid extraction kits, molecular diagnostic tests, thermal cyclers, microarray readers and software. Its products find applications in therapeutical areas of infectious disease, oncology and pharmacogenomics, among others. Akonni Biosystems uses its technologies for specimen homogenization, cell lysis, nucleic acid purification, thermal cycling, 3D gel drop microarrays, microfluidics and software analysis. The company partners with laboratories, biodefense companies and universities. It markets its products across the US. Akonni Biosystems is headquartered in Frederick, Maryland, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

• The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
• The report analyzes all pipeline products in development for the company Akonni Biosystems Inc
• The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
• The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
• The report provides detailed description of products in development, technical specification and functions
• The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

• Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
• Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
• To formulate effective Research & Development strategies
• Develop market-entry and market expansion strategies
• Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
• Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Key Topics Covered:

• Akonni Biosystems Inc Company Overview
• Akonni Biosystems Inc Company Snapshot
• Akonni Biosystems Inc Pipeline Products and Ongoing Clinical Trials Overview
• Akonni Biosystems Inc - Pipeline Analysis Overview
• Akonni Biosystems Inc - Key Facts
• Akonni Biosystems Inc - Major Products and Services
• Akonni Biosystems Inc Pipeline Products by Development Stage
• Akonni Biosystems Inc Pipeline Products Overview
• Array-Based Portable Pathogen Detection System
• Array-Based Portable Pathogen Detection System Product Overview
• Lab-On-A-Film
• Lab-On-A-Film Product Overview
• Multiplexed Diagnostic Test - Aseptic Encephalitis
• Nucleic Acid Extraction Device - Tuberculosis
• Protein Array Test Cartridge
• RT-PCR Microarray Assay
• TruArray BTA Test
• TruArray HE Test Kit
• TruArray MDR - TB Test Kit
• TruArray MRSA Assay
• TruArrayab URI
• TruDiagnosis - Pharmacogenomic Test
• TruDx 2000 Platform
• TruTip Automated Workstation
• Akonni Biosystems Inc - Key Competitors
• Akonni Biosystems Inc - Key Employees
• Akonni Biosystems Inc - Locations And Subsidiaries
• Head Office
• Recent Developments
• Akonni Biosystems Inc, Recent Developments
• Jun 06, 2019: Akonni Biosystems receives FDA 510(k) clearance of its TruDiagnosis Multiplex Diagnostic System
• Feb 05, 2019: Akonni Biosystems awarded phase II NIH contract to advance its device to purify DNA from sputum for tuberculosis testing
• Jan 04, 2019: Akonni Biosystems announces FDA 510(k) submission for its TruDiagnosis multiplex diagnostic system
• Aug 21, 2018: VitalHub announces sale of TREAT EHR System to youth mental health facility
• Aug 21, 2018: Akonni Biosystems awarded NIH grant to support the advancement of its point-of-care diagnostic platform
• Jun 13, 2018: Akonni Biosystems Appoints Lawrence Firestone As Executive Vice President And Chief Financial Officer
• Nov 14, 2017: Akonni Biosystems Awarded NIH Grant to Support Commercialization of a Low-Cost, Simple, Rapid Point-Of-Care Test for Tuberculosis and its Resistance to First-Line Drugs
• Oct 17, 2017: Akonni Biosystems Awarded Grant to Evaluate the TruDiagnosis Molecular Diagnostics Platform for Use in Low Resource Settings
• Aug 09, 2017: Akonni Biosystems Awarded NIH Contract to Develop a Non-Invasive Rapid Diagnostic for Lower Respiratory Diseases in Children
• Jun 27, 2017: Akonni Biosystems Elects Brian J. Morra as Executive Chairman of the Board
• Appendix
• Methodology
• About the Author
• Contact Us
• Disclaimer

Companies Mentioned

• Allwin Medical Devices
• Novartis Vaccines and Diagnostics Inc
• ACEA Biosciences Inc
• BioTek Instruments Inc

For more information about this company profile visit https://www.researchandmarkets.com/r/8a7lts